Valuation: Byotrol plc

Market Cap 194K 260K 227K 210K 368K 24.8M 374K 2.51M 984K 12.22M 976K 955K 42M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.13M 992K 915K 1.6M 108M 1.63M 10.93M 4.29M 53.26M 4.26M 4.16M 183M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 01/07/2024
Director TitleAgeSince
Director/Board Member 50 13/12/2021
Chairman 75 22/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
+0.13%-2.89%-7.22%-1.22% 342B
+1.05%-0.45%-9.72%+2.30% 133B
+1.35%-3.04%+1.79%+21.54% 73.81B
+0.28%-2.30%-10.70%-19.05% 52.98B
+1.56%-1.77%-6.88%-22.85% 37.4B
+0.82%-1.25%-10.25%-57.22% 29.91B
+0.25%-0.14%+3.85%+0.18% 19.59B
+1.43%+1.70%-29.83%-33.26% 19.44B
-1.86%-2.13%-1.95%+19.87% 18.03B
Average -1.43%-1.36%-7.88%-9.97% 80.78B
Weighted average by Cap. +0.83%-2.07%-7.30%-3.28%

Financials

2023 2024
Net sales 4.59M 6.16M 5.39M 4.97M 8.71M 588M 8.86M 59.41M 23.33M 290M 23.14M 22.63M 995M 3.97M 5.33M 4.66M 4.3M 7.53M 508M 7.66M 51.36M 20.17M 250M 20M 19.57M 861M
Net income -1.69M -2.27M -1.99M -1.83M -3.21M -217M -3.26M -21.89M -8.6M -107M -8.53M -8.34M -367M -3.06M -4.11M -3.6M -3.32M -5.81M -392M -5.91M -39.64M -15.57M -193M -15.44M -15.1M -664M
Net Debt 287K 385K 337K 311K 545K 36.73M 554K 3.71M 1.46M 18.1M 1.45M 1.41M 62.21M 651K 874K 764K 705K 1.24M 83.32M 1.26M 8.42M 3.31M 41.05M 3.28M 3.21M 141M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35